Search

everythinglearnresearchcommunity

for

Search:↓

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Higher IL-17A levels indicate more severe alopecia areata.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Autoimmune diseases can change hair texture, but treatment can restore it.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

SLE and DM can coexist but are rare and need careful evaluation.

Hydroxychloroquine may help COVID-19 patients with lupus.

Tph cells are linked to the severity of systemic lupus erythematosus.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The machine learning model accurately predicts Systemic Lupus Erythematosus in Omani patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Higher EULAR/ACR scores in SLE patients predict more organ damage.